Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (81-90 of 408) with videos related to

Pageof 41
Sort By:
Cytokine|December 26, 2012
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokineAndrea Cossu, Ele Ferrannini, Poupak Fallahi, et al.
The American Journal of the Medical Sciences|September 17, 2008
Thyroid-associated ophthalmopathy and TSH receptor autoantibodies in nonmetastatic thyroid cancer after total thyroidectomyAlessandro Antonelli, Poupak Fallahi, Simone Tolari, et al.
Diabetes|July 26, 2013
Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acidsRebecca A Haeusler, Brenno Astiarraga, Stefania Camastra, et al.
Diabetes & Vascular Disease Research|April 10, 2008
Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitusDarren K McGuire, Jeffrey R Winterfield, Jason A Rytlewski, et al.
Cytokine & Growth Factor Reviews|February 18, 2014
CXCR3, CXCL10 and type 1 diabetesAlessandro Antonelli, Silvia Martina Ferrari, Alda Corrado, et al.
International Journal of Cardiology|September 6, 2003
A comparative study of the in vitro antioxidant activity of statinsFerdinando Franzoni, Alfredo Quiñones-Galvan, Francesco Regoli, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapyAlessandro Antonelli, Silvia Martina Ferrari, Alda Corrado, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 4, 2004
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal testsAndrea Mari, Amalia Gastaldelli, Andrea Natali, et al.
The American Journal of Cardiology|July 7, 2009
Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14)Robert Spanheimer, D John Betteridge, Meng H Tan, et al.
Endocrinology|February 7, 2009
Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtypeEleonora Santini, Sabina Cuccato, Stephanie Madec, et al.
Pageof 41

Showing results (81-90 of 408) with videos related to

Sort By:
Pageof 41
Cytokine|December 26, 2012
Antibodies recognizing specific Mycobacterium avium subsp. paratuberculosis's MAP3738c protein in type 1 diabetes mellitus children are associated with serum Th1 (CXCL10) chemokineAndrea Cossu, Ele Ferrannini, Poupak Fallahi, et al.
The American Journal of the Medical Sciences|September 17, 2008
Thyroid-associated ophthalmopathy and TSH receptor autoantibodies in nonmetastatic thyroid cancer after total thyroidectomyAlessandro Antonelli, Poupak Fallahi, Simone Tolari, et al.
Diabetes|July 26, 2013
Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acidsRebecca A Haeusler, Brenno Astiarraga, Stefania Camastra, et al.
Diabetes & Vascular Disease Research|April 10, 2008
Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitusDarren K McGuire, Jeffrey R Winterfield, Jason A Rytlewski, et al.
Cytokine & Growth Factor Reviews|February 18, 2014
CXCR3, CXCL10 and type 1 diabetesAlessandro Antonelli, Silvia Martina Ferrari, Alda Corrado, et al.
International Journal of Cardiology|September 6, 2003
A comparative study of the in vitro antioxidant activity of statinsFerdinando Franzoni, Alfredo Quiñones-Galvan, Francesco Regoli, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapyAlessandro Antonelli, Silvia Martina Ferrari, Alda Corrado, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 4, 2004
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal testsAndrea Mari, Amalia Gastaldelli, Andrea Natali, et al.
The American Journal of Cardiology|July 7, 2009
Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14)Robert Spanheimer, D John Betteridge, Meng H Tan, et al.
Endocrinology|February 7, 2009
Extracellular adenosine 5'-triphosphate modulates insulin secretion via functionally active purinergic receptors of X and Y subtypeEleonora Santini, Sabina Cuccato, Stephanie Madec, et al.
Pageof 41